McMinn Rachel
Insider CIK 1606302 · ICPT Chief Strategy Officer · NGNE Chief Executive Officer, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| NGNE Neurogene Inc. | M Exercise deriv | 2026-09-22 | 2026-10-02 | 756 | — | $0 | 0 | SEC↗ |
| NGNE Neurogene Inc. | M Exercise | 2026-09-22 | 2026-10-02 | 756 | $25.32 | $19.1K | 1,345,063 | SEC↗ |
| NGNE Neurogene Inc. | S Sale | 2026-03-26 | 2026-03-30 | 3,352 | $22.07 | $74.0K | 1,344,307 | SEC↗ |
| NGNE Neurogene Inc. | A Award deriv | 2026-02-20 | 2026-02-24 | 155,100 | — | $0 | 155,100 | SEC↗ |
| NGNE Neurogene Inc. | A Award | 2026-02-20 | 2026-02-24 | 25,900 | — | $0 | 1,347,659 | SEC↗ |
| NGNE Neurogene Inc. | A Award deriv | 2025-03-26 | 2025-03-28 | 143,500 | — | $0 | 143,500 | SEC↗ |
| NGNE Neurogene Inc. | A Award | 2025-03-26 | 2025-03-28 | 23,900 | — | $0 | 1,274,259 | SEC↗ |
| NGNE Neurogene Inc. | P Buy | 2024-11-22 | 2024-11-25 | 47,500 | $20.40 | $969.0K | 1,297,859 | SEC↗ |
| NGNE Neurogene Inc. | A Award deriv | 2024-03-13 | 2024-03-14 | 93,282 | — | $0 | 93,282 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2017-10-02 | 2017-10-04 | 283 | $58.89 | $16.7K | 16,875 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2017-07-31 | 2017-08-02 | 130 | $123.12 | $16.0K | 17,158 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2017-07-03 | 2017-07-05 | 257 | $121.78 | $31.3K | 17,288 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2017-05-01 | 2017-05-03 | 114 | $113.12 | $12.9K | 17,545 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2017-04-03 | 2017-04-05 | 257 | $115.00 | $29.6K | 17,659 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | A Award deriv | 2017-02-01 | 2017-02-03 | 8,300 | — | $0 | 8,300 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | A Award | 2017-02-01 | 2017-02-03 | 5,000 | — | $0 | 17,916 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2017-01-03 | 2017-01-05 | 816 | $103.92 | $84.8K | 12,916 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2016-10-31 | 2016-11-02 | 129 | $123.82 | $16.0K | 13,732 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2016-08-01 | 2016-08-02 | 125 | $176.57 | $22.1K | 13,861 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2016-07-05 | 2016-07-07 | 106 | $145.11 | $15.4K | 13,986 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2016-05-02 | 2016-05-04 | 130 | $147.49 | $19.2K | 14,087 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2016-04-04 | 2016-04-06 | 104 | $130.76 | $13.6K | 14,217 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | A Award deriv | 2016-02-10 | 2016-02-12 | 8,800 | — | $0 | 8,800 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | A Award | 2016-02-10 | 2016-02-12 | 6,700 | — | $0 | 14,321 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2016-02-01 | 2016-02-03 | 128 | $103.56 | $13.3K | 7,621 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2016-01-04 | 2016-01-05 | 469 | $145.90 | $68.4K | 7,749 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-11-02 | 2015-11-04 | 125 | $160.24 | $20.0K | 8,218 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | A Award deriv | 2015-10-01 | 2015-10-05 | 10,600 | — | $0 | 10,600 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | A Award | 2015-10-01 | 2015-10-05 | 4,050 | — | $0 | 8,343 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-07-31 | 2015-08-04 | 127 | $262.09 | $33.3K | 4,293 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-05-01 | 2015-07-17 | 503 | $255.12 | $128.3K | 4,420 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | A Award deriv | 2014-04-30 | 2014-05-02 | 6,467 | — | $0 | 6,467 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | A Award deriv | 2014-04-30 | 2014-05-02 | 6,004 | — | $0 | 6,004 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | A Award | 2014-04-30 | 2014-05-02 | 4,923 | — | $0 | 4,923 | SEC↗ |